Cargando…
Success and Limitation of Equine Influenza Vaccination: The First Incursion in a Decade of a Florida Clade 1 Equine Influenza Virus that Shakes Protection Despite High Vaccine Coverage
Every year, several epizooties of equine influenza (EI) are reported worldwide. However, no EI case has been identified in France between 2015 and late 2018, despite an effective field surveillance of the pathogen and the disease. Vaccination against equine influenza virus (EIV) remains to this day...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963532/ https://www.ncbi.nlm.nih.gov/pubmed/31684097 http://dx.doi.org/10.3390/vaccines7040174 |
_version_ | 1783488301212106752 |
---|---|
author | Fougerolle, Stéphanie Fortier, Christine Legrand, Loïc Jourdan, Marion Marcillaud-Pitel, Christel Pronost, Stéphane Paillot, Romain |
author_facet | Fougerolle, Stéphanie Fortier, Christine Legrand, Loïc Jourdan, Marion Marcillaud-Pitel, Christel Pronost, Stéphane Paillot, Romain |
author_sort | Fougerolle, Stéphanie |
collection | PubMed |
description | Every year, several epizooties of equine influenza (EI) are reported worldwide. However, no EI case has been identified in France between 2015 and late 2018, despite an effective field surveillance of the pathogen and the disease. Vaccination against equine influenza virus (EIV) remains to this day one of the most effective methods to prevent or limit EI outbreaks and the lack of detection of the pathogen could be linked to vaccination coverage. The aim of this study was to evaluate EI immunity and vaccine coverage in France through a large-scale serological study. A total of 3004 archived surplus serums from French horses of all ages, breeds and sexes were selected from four different geographical regions and categories (i.e., sanitary check prior to exportation, sale, breeding protocol or illness diagnosis). EIV-specific antibody response was measured by single radial hemolysis (SRH) and an EIV-nucleoprotein (NP) ELISA (used as a DIVA test). Overall immunity coverage against EIV infection (i.e., titers induced by vaccination and/or natural infection above the clinical protection threshold) reached 87.6%. The EIV NP ELISA results showed that 83% of SRH positive serum samples from young horses (≤3 years old) did not have NP antibodies, which indicates that the SRH antibody response was likely induced by EI vaccination alone (the HA recombinant canarypoxvirus-based EI vaccine is mostly used in France) and supports the absence of EIV circulation in French horse populations between 2015 and late 2018, as reported by the French equine infectious diseases surveillance network (RESPE). Results from this study confirm a strong EI immunity in a large cohort of French horses, which provides an explanation to the lack of clinical EI in France in recent years and highlights the success of vaccination against this disease. However, such EI protection has been challenged since late 2018 by the incursion in the EU of a Florida Clade 1 sub-lineage EIV (undetected in France since 2009), which is also reported here. |
format | Online Article Text |
id | pubmed-6963532 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69635322020-01-30 Success and Limitation of Equine Influenza Vaccination: The First Incursion in a Decade of a Florida Clade 1 Equine Influenza Virus that Shakes Protection Despite High Vaccine Coverage Fougerolle, Stéphanie Fortier, Christine Legrand, Loïc Jourdan, Marion Marcillaud-Pitel, Christel Pronost, Stéphane Paillot, Romain Vaccines (Basel) Article Every year, several epizooties of equine influenza (EI) are reported worldwide. However, no EI case has been identified in France between 2015 and late 2018, despite an effective field surveillance of the pathogen and the disease. Vaccination against equine influenza virus (EIV) remains to this day one of the most effective methods to prevent or limit EI outbreaks and the lack of detection of the pathogen could be linked to vaccination coverage. The aim of this study was to evaluate EI immunity and vaccine coverage in France through a large-scale serological study. A total of 3004 archived surplus serums from French horses of all ages, breeds and sexes were selected from four different geographical regions and categories (i.e., sanitary check prior to exportation, sale, breeding protocol or illness diagnosis). EIV-specific antibody response was measured by single radial hemolysis (SRH) and an EIV-nucleoprotein (NP) ELISA (used as a DIVA test). Overall immunity coverage against EIV infection (i.e., titers induced by vaccination and/or natural infection above the clinical protection threshold) reached 87.6%. The EIV NP ELISA results showed that 83% of SRH positive serum samples from young horses (≤3 years old) did not have NP antibodies, which indicates that the SRH antibody response was likely induced by EI vaccination alone (the HA recombinant canarypoxvirus-based EI vaccine is mostly used in France) and supports the absence of EIV circulation in French horse populations between 2015 and late 2018, as reported by the French equine infectious diseases surveillance network (RESPE). Results from this study confirm a strong EI immunity in a large cohort of French horses, which provides an explanation to the lack of clinical EI in France in recent years and highlights the success of vaccination against this disease. However, such EI protection has been challenged since late 2018 by the incursion in the EU of a Florida Clade 1 sub-lineage EIV (undetected in France since 2009), which is also reported here. MDPI 2019-11-02 /pmc/articles/PMC6963532/ /pubmed/31684097 http://dx.doi.org/10.3390/vaccines7040174 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Fougerolle, Stéphanie Fortier, Christine Legrand, Loïc Jourdan, Marion Marcillaud-Pitel, Christel Pronost, Stéphane Paillot, Romain Success and Limitation of Equine Influenza Vaccination: The First Incursion in a Decade of a Florida Clade 1 Equine Influenza Virus that Shakes Protection Despite High Vaccine Coverage |
title | Success and Limitation of Equine Influenza Vaccination: The First Incursion in a Decade of a Florida Clade 1 Equine Influenza Virus that Shakes Protection Despite High Vaccine Coverage |
title_full | Success and Limitation of Equine Influenza Vaccination: The First Incursion in a Decade of a Florida Clade 1 Equine Influenza Virus that Shakes Protection Despite High Vaccine Coverage |
title_fullStr | Success and Limitation of Equine Influenza Vaccination: The First Incursion in a Decade of a Florida Clade 1 Equine Influenza Virus that Shakes Protection Despite High Vaccine Coverage |
title_full_unstemmed | Success and Limitation of Equine Influenza Vaccination: The First Incursion in a Decade of a Florida Clade 1 Equine Influenza Virus that Shakes Protection Despite High Vaccine Coverage |
title_short | Success and Limitation of Equine Influenza Vaccination: The First Incursion in a Decade of a Florida Clade 1 Equine Influenza Virus that Shakes Protection Despite High Vaccine Coverage |
title_sort | success and limitation of equine influenza vaccination: the first incursion in a decade of a florida clade 1 equine influenza virus that shakes protection despite high vaccine coverage |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963532/ https://www.ncbi.nlm.nih.gov/pubmed/31684097 http://dx.doi.org/10.3390/vaccines7040174 |
work_keys_str_mv | AT fougerollestephanie successandlimitationofequineinfluenzavaccinationthefirstincursioninadecadeofafloridaclade1equineinfluenzavirusthatshakesprotectiondespitehighvaccinecoverage AT fortierchristine successandlimitationofequineinfluenzavaccinationthefirstincursioninadecadeofafloridaclade1equineinfluenzavirusthatshakesprotectiondespitehighvaccinecoverage AT legrandloic successandlimitationofequineinfluenzavaccinationthefirstincursioninadecadeofafloridaclade1equineinfluenzavirusthatshakesprotectiondespitehighvaccinecoverage AT jourdanmarion successandlimitationofequineinfluenzavaccinationthefirstincursioninadecadeofafloridaclade1equineinfluenzavirusthatshakesprotectiondespitehighvaccinecoverage AT marcillaudpitelchristel successandlimitationofequineinfluenzavaccinationthefirstincursioninadecadeofafloridaclade1equineinfluenzavirusthatshakesprotectiondespitehighvaccinecoverage AT pronoststephane successandlimitationofequineinfluenzavaccinationthefirstincursioninadecadeofafloridaclade1equineinfluenzavirusthatshakesprotectiondespitehighvaccinecoverage AT paillotromain successandlimitationofequineinfluenzavaccinationthefirstincursioninadecadeofafloridaclade1equineinfluenzavirusthatshakesprotectiondespitehighvaccinecoverage |